No Data
No Data
December 27 [Today's Investment Strategy]
[Selected Stocks by Fisco] 【Material Stocks】 Kaken Pharmaceutical <4521> 4174 yen (12/26) Main products include the nail fungus treatment 'Klenafin' and the joint function improvement drug 'Alts'. The company announced the signing of a contract granting Johnson & Johnson exclusive rights for the development, manufacturing, and commercialization globally of the 'STAT6 Program', which is being developed as a next-generation oral treatment for type 2 inflammatory diseases (such as atopic dermatitis and asthma).
Steady, a sense of relief with the rise in long-term US Gold interest rates coming to a pause.
[Emerging Markets Individual Stock Global Strategy] Today's Emerging Markets are expected to show a solid performance. In the US stock market on the 26th, the Dow Inc rose by 28.77 dollars (+0.07%) to 43,325.80 dollars, marking a slight fifth consecutive gain. In the morning, selling was dominant as there was a surprising decrease in unemployment Insurance claims, leading to rising long-term interest rates. However, as the number of continuing unemployment Insurance beneficiaries reached a three-year high and the strong results of the 7-year bond auction caused interest rates to turn downward, buying became strong toward the end, and the Dow was...
Focus on DeNA and Kaken Pharmaceutical, while Oisix and Sankyo Tateyama may be sluggish.
In the US stock market on the 26th, the Dow Jones Industrial Average rose by $28.77 to 43,325.80, the Nasdaq Composite Index fell by 10.77 points to 20,020.36, and the Chicago Nikkei 225 Futures were up by 210 yen compared to Osaka daytime at 39,700 yen. The exchange rate was 1 dollar = 158.00-10 yen. In today's Tokyo market, Kusuri no Aoki <3549> saw an increase in operating profit of 85.5%, expanding from 10.2% growth in the first quarter, and the performance of its gaming business for the fiscal year ending in March 2025 is expected to see an increase in both revenue and profit compared to the previous period.
Rena Science, Genie and others.
The complete acquisition and cancellation of the remaining 27th subscription rights of Shannon (with exercise price adjustment clause) and the issuance of the 23rd subscription rights (with exercise price adjustment clause) (number of potential Stocks 1.37 million 4,600 stocks, raised approximately 0.143 billion yen) issuance of the 24th subscription rights (with exercise price adjustment clause) (number of potential Stocks 6 million stocks, raised approximately 0.567 billion yen) acquisition of BASEE store's Stocks (4304) and making it a subsidiary, and the remaining 15th and 18th subscription rights of Kids Bio (4584).
Individual investor, Limited Tei Gyokusuke: Currently focusing on AI-related and high-performing stocks! What are the stocks that have recently become STAR?
The following is a comment written by the individual investor "Yuumitei Gyokusuke" (blog: Profitable Stock Information "Cat Husband's Stocks Know No Bounds") from Fisco Social Reporter. Fisco strives to collaborate with individuals who actively disseminate information to provide a more diverse array of information to investors. ----------- *Written on December 15, 2024, at 11:00 AM, the third-quarter earnings of Dutch ALSM for 2024 did not meet market expectations, leading to an AI Semiconductors boom.
Volume change rate ranking (10 o'clock) - SMN, Fisco, etc. ranked in.
In the volume change rate ranking, you can understand the market participants' interests such as trends in speculation by comparing the average volume of the past 5 days with the volume on the delivery day. Top volume change rate [as of 10:32 on December 5] (comparison of average volume of the past 5 days) Stock Code Stock Name Volume 5-day Average Volume Volume Change Rate Stock Price Change Rate <6185> SMN 449100 11548.32 299.24% 0.155% <1305> iFTPX year.